產品介紹
產品介紹
PIPELINE
台康生技開發高質量的生物產品，推進廣泛的候選產品線，以改善患者的生活。
| 產品名稱 | 藥物類別 | 適應症 | 標靶/靶點 | 研發進度 | 合作夥伴 | |||
|---|---|---|---|---|---|---|---|---|
| 臨床前試驗 | 臨床一期 | 臨床二/三期 | 上市許可申請 | |||||
EG12014 (EIRGASUN®/HERWENDA®) Trastuzumab Biosimilar | Monoclonal Antibody | Breast Cancer | HER 2 |  |  | |||
EG1206A Pertuzumab Biosimilar | Monoclonal Antibody | Breast Cancer | HER 2 | |  | |||
EG12043 (TSY0110) Ado-trastuzumab emtansine Biosimilar | Antibody Drug Conjugate (ADC) | Breast Cancer | HER 2 | |  | |||
EG13074 TRZ (SC formulation) | Monoclonal Antibody | Breast Cancer | HER 2 | | - | |||
EG13084 TRZ + PTZ (SC formulation) | Monoclonal Antibody | Breast Cancer | HER 2 | | - | |||
EG1211X IO | Monoclonal Antibody | Breast Cancer | PD-L1 | | - | |||
EG1216X Hemato-oncology | Monoclonal Antibody | Breast Cancer | CD38 | | - | |||